UnitedHealth Group Stock Holds Firm Amid Q2 Earnings Beat and Raised EPS Guidance
UnitedHealth Group's stock price held firm at just under $394 per share on August 28, 2026, as investors digested a solid Q2 2026 earnings beat and raised full-year EPS guidance.
The healthcare giant reported second-quarter revenues of $112.03 billion, with adjusted earnings per share of $6.38, surpassing analyst expectations.
Management attributed the strong performance to improved medical cost ratios and robust Optum operating results, which jumped 29% to $4 billion in Q2 2026.